Drug interaction in a renal transplant patient: Cyclosporin-neoral and Orlistat

American Journal of Kidney Diseases

Volumn 41, Issue 2, 2003, Pages 493-496

  Evans, Sally ^a   Michael, Robson ^a   Wells, Hayley ^a   MacLean, Douglas ^a   Gordon, Isabel ^a   Taylor, John ^a   Goldsmith, David ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

C2 monitoring; Cyclosporin A (CyA); Drug interaction; Pharmacokinetics; Transplantation; Xenical

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BASILIXIMAB; COTRIMOXAZOLE; CYCLOSPORIN A; ENALAPRIL; INSULIN; PREDNISOLONE; RANITIDINE; SIMVASTATIN; TETRAHYDROLIPSTATIN;

ABDOMINAL PAIN; ADULT; ARTICLE; BODY MASS; CASE REPORT; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; FLATULENCE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERITONEAL DIALYSIS; STEATORRHEA; STOMACH EMPTYING;

EID: 0037311063     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50061     Document Type: Article

References (9)

1. Margreiter R: Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomised multicentre study. Lancet 359:741-746, 1996
2. Ballinger A: Orlistat in the treatment of obesity. Expert Opin Pharmacother 1:841-847, 2000
3. Levy GA: C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation. BioDrugs 15:279-290, 2001
4. Canadian Neoral Renal Transplantation Study Group: Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation. Transplantation 72:1024-1032, 2001
5. Hennessy M, Kelleher D, Spiers JP, et al: St. John's Wort increases expression of P-glycoprotein: Implications for drug interactions. Br J Clin Pharmacol 53:75-82, 2002
6. Nagele H, Petersen B, Bonacker U, Rodiger W: Effect of orlistat on blood cyclosporin concentration in an obese heart transplant patient. Eur J Clin Pharmacol 55:667-669, 1999
7. Schnetzler B, Kondo-Oestreicher M, Vala D, Khatchatourian G, Faidutti B: Orlistat decreases the plasma level of cyclosporine and may be responsible for the development of acute rejection episodes. Transplantation 70:1540-1541, 2000
8. Le Beller C, Bezie Y, Chabatte C, Guillemain R, Amrein C, Billaud EM: Co-administration of Orlistat and Cyclosporine in a heart transplant patient. Transplantation 70:1541, 2000
9. Colman E, Fossler M: Reduction in blood cyclosporine concentrations by of orlistat. N Engl J Med 342:1141-1142, 2000